Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 576
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
25380
Anyone have Bertolino's company email address -
djs7
07/14/2016 8:55:01 PM
25378
Neither I nor anyone else has proprietary data
Drano
07/14/2016 8:49:23 PM
25377
Well, can you or someone knowing biotech numbers
djs7
07/14/2016 8:44:31 PM
25376
We. Don't. Know. Squat. about what is going on
Drano
07/14/2016 8:34:30 PM
25375
yeah .. i know i'm funny that way you have a good
4kids
07/14/2016 8:31:16 PM
25373
Sure would like to know why they couldn't find a
djs7
07/14/2016 8:27:37 PM
25371
done .. sent to ih admin via
(2)
4kids
07/14/2016 8:14:37 PM
25369
Just want to remind readers that you can request
sox0407
07/14/2016 8:06:02 PM
25364
We've already banned this one a couple of times
Drano
07/14/2016 7:46:53 PM
25363
FUD starting opinions and lies as fact to try and
daydreaming2
07/14/2016 7:44:37 PM
25360
Ignoring trolls is the best strategy
Drano
07/14/2016 7:09:49 PM
25359
If he gave you a fake name, what makes you think
sox0407
07/14/2016 6:32:04 PM
25357
I was praising Dr. B. Saying Person A doing a
sox0407
07/14/2016 6:26:39 PM
25356
That's impressive! Is that his real name? The
sox0407
07/14/2016 6:22:54 PM
25352
It'll be great if you can list some informative
sox0407
07/14/2016 6:12:59 PM
25351
8-K filed today about the interview.
sox0407
07/14/2016 6:07:46 PM
25348
@ Drano - I've heard enough from this guy. His
(3)
thefamilyman
07/14/2016 5:55:35 PM
25347
so here is what i see .. re: tape of trades ..
4kids
07/14/2016 5:55:05 PM
25346
FINRA short sales of CTIX
AlanC
07/14/2016 5:47:26 PM
25345
nobody has a big enough farm to spread your
daydreaming2
07/14/2016 5:08:35 PM
25344
yep and what is even more repulsive is knowing
(1)
4kids
07/14/2016 5:02:19 PM
25342
Christ, I need a shower after reading that. In a
scgmck1
07/14/2016 4:47:00 PM
25341
oh i have no doubts about signals embedded .. but
(1)
4kids
07/14/2016 4:42:39 PM
25340
For anyone who thinks those "signal" trades are
(1)
Drano
07/14/2016 4:41:02 PM
25339
it becomes very revealing when noted
4kids
07/14/2016 4:40:43 PM
25338
Thanks. That's pretty stunning. I like the 10-15k
Drano
07/14/2016 4:36:36 PM
25337
this is the cynic in me as to how i see some of
(2)
4kids
07/14/2016 4:33:57 PM
25336
CELLCEUTIX CORPORATION 1.22Down -0.06 (-4.69 %)AS
4kids
07/14/2016 4:25:36 PM
25335
1400 shares on offer at 1.22-1.26. Then nothing
Drano
07/14/2016 4:02:45 PM
25334
According to that otcmarkets site, not much
Drano
07/14/2016 3:59:41 PM
25333
Distorting other people's posts is a favorite
Drano
07/14/2016 3:57:13 PM
25332
just a piece of advice for this venue .. (SMB)
4kids
07/14/2016 3:55:54 PM
25330
One would think they have enough whining to
incubus
07/14/2016 3:48:49 PM
25329
Just made it happen. Much better.
incubus
07/14/2016 3:46:34 PM
25328
I was debating whether it was scott or booby but
Drano
07/14/2016 3:45:46 PM
25327
So the new whiner and attack dog. If you don't
(2)
incubus
07/14/2016 3:44:43 PM
25324
From the interview with Dr.B that KarinCa did
scgmck1
07/14/2016 3:39:24 PM
25323
A reminder of how to ignore a poster: you click
Drano
07/14/2016 3:34:47 PM
25322
The company has stated that there were problems
Drano
07/14/2016 3:33:45 PM
25320
Ah, gotcha. That's a trading strategy I would
Drano
07/14/2016 3:31:17 PM
25319
Drano Leo said that 6 months ago. Look the PR up.
BLDM
07/14/2016 3:31:03 PM
25318
If someone who owns both stocks saw ARTH tanking
TheDane
07/14/2016 3:27:56 PM
25317
The Bril-OM trial was the proof of concept to
Drano
07/14/2016 3:26:43 PM
25316
You must be unaware that the company announced
Drano
07/14/2016 3:24:14 PM
25315
Sounds to me like Cellceutix should have done the
BLDM
07/14/2016 3:20:19 PM
25314
They haven't done 3/5 of the patients in 14
BLDM
07/14/2016 3:17:06 PM
25313
$CTIX .. retail investors might find this data
4kids
07/14/2016 3:15:32 PM
25312
I know that you referred to UP. Read my response
(2)
Drano
07/14/2016 3:10:51 PM
25311
I didn't say what if OM fails I said UP. If UP
(1)
BLDM
07/14/2016 3:08:30 PM
25310
Not following you -- why would ARTH's problem
(1)
Drano
07/14/2016 3:06:37 PM
Newer
Older
Recent Articles
Unlocking the Future: The Role of Trust in AI Advancement
Sobi Reports Q2 2025: Impressive Growth and Future Outlook
Sobi Reports Robust Performance in Q2 2025 Financials
Explore CJB Crypto's Innovative Green Mining Solutions
Join Tetragon Financial Group Limited for Upcoming Investor Call
Synovus Financial Earnings Expectations and Analyst Insights
Exploring Growth in the Projection Mapping Industry Through 2032
ICG Achieves Strong Growth with $123bn in Q1 Trading
Hofseth BioCare's ProGo® Triumphs at NutraIngredients Awards
IMCD Strengthens Leadership with New Executive Appointments
Nilörn Group Sees Mixed Financial Results for Q2 2025
Kenmare Resources Q2 2025 Production Update Highlights
Foresight Group's Strategic Share Buyback Initiative Explained
Caledonia Mining Reports Record Gold Production in Q2 2025
Stellantis Shifts Focus Away from Hydrogen Fuel Cell Development
Bitget Expands Token Offerings with Eclipse Listing and Rewards
Hofseth BioCare's ProGo® Earns Top Honors for Healthy Aging
Leadership Changes at IMCD to Enhance Global Operations
Kenmare Resources Reports Solid Production Results for 2025
ICG's Q1 Performance Review: Insights on Fundraising Growth
Nilörn Reports Insights from Q2 2025 Business Performance
Tetragon Financial Group: Upcoming Investor Call Insights
Xlence Unveils Trading Central Suite for Enhanced Trading Success
Innovative Global Healthcare Challenge Spotlights Emerging Startups
Elevating In-Car Entertainment: LG's webOS in New Kia Models
Experience Premium In-Car Entertainment with LG and Kia
ESET PROTECT Complete: Leaders in Cybersecurity Solutions 2025
Richemont Achieves Strong Growth in Q1 Sales Performance
Economist Peter Schiff Forecasts Market Reaction to Trump’s Tariffs
Nuwellis Achieves Significant Growth with New Patent Approval
Alm. Brand Group Reports Impressive Q2 Financial Results
Ocuco Faces Scrutiny After Massive Data Breach Affecting Patients
London Properties, Inc. Faces Scrutiny Over Data Breach
Investigation into ACCU Reference Medical Lab for Data Breach
Innovative Cybersecurity Solutions Earn Penta Recognition
ESET PROTECT Complete: The Future of Malware Protection
Promising Q2 Results: Alm. Brand Group's Solid Performance Overview
DNO ASA Temporarily Halts Operations Amidst Unexpected Incidents
Bitget Wallet Launches Weekly Staking Event with PUMP Tokens
ASML Reports Strong Q2 Performance with €7.7B in Sales
Borregaard ASA Achieves Significant Growth in 2nd Quarter
Ontex Revises 2025 Outlook Amid Falling Revenues and Margins
Aker ASA's Robust Financial Performance in 2025 Revealed
Market Watch: Inflation Raises Eyebrows as Fed Adjustments Loom
Argo Appoints Wilbert Landry to Boost Board Strength
ASML's Impressive Q2 Results Showcase Strong Growth Outlook
Sanofi's Innovative Gene Therapy Receives Fast Track Status
Ontex's Q1 Report: Navigating Market Challenges with Resilience
Exploring Pluxee N.V.'s Financial Liquidity Developments
Borregaard ASA Reports Robust Performance with Increased EBITDA